Dr Mathew Horrocks MRSC
Winner: 2022 Analytical Division early career award: Joseph Black Award
The University of Edinburgh
For the development and application of single-molecule and super-resolution microscopy approaches to understand how proteins aggregate in neurodegenerative diseases.
Celebrate Dr Mathew Horrocks
#RSCPrizes
Neurodegenerative disorders cause much suffering to those living with them and their carers, and it is the hope that we will one day be able to diagnose them earlier and find a cure that motivates me.
Neurodegenerative disorders affect 850,000 people in the UK, and with an ageing population, this number is expected to rise to 1,000,000 by 2025. In addition to the major personal burden of these diseases, each year dementia costs the UK an estimated £26 billion, a number which is also expected to increase. Of these disorders, Alzheimer's and Parkinson's diseases are the most common. Both diseases can only be diagnosed clinically based on patient symptoms, with confirmation post mortem. There are currently no suitable biomarkers, which is a result of a shortfall in the technologies sensitive enough to detect potential targets. The lack of an early diagnosis also limits the development of therapeutic interventions. By the time the symptoms become evident, much of the damage in the brain has occurred, and this is currently irreversible.
In both diseases, small protein clumps – called oligomers – form in the brain and are difficult to study due to their structure and size. Mathew has spent his research career developing powerful microscopy methods to see and characterise these disease-causing agents.
This research is increasing our understanding of how oligomers are formed, how they cause damage, and how cells respond to prevent damage.
Read winner biography